Literature DB >> 29408193

Global incidence and mortality rates in pancreatic cancer and the association with the Human Development Index: decomposition approach.

Y Veisani1, E Jenabi2, S Khazaei3, Sh Nematollahi4.   

Abstract

OBJECTIVES: Pancreatic cancer has a lower morbidity yet higher case fatality rates (CFRs) compared with other gastrointestinal cancers. The effects of socio-economic components on pancreatic cancer rates have been acknowledged; however, the effects of the Human Development Index (HDI) inequality are not. In this study, we aimed to determine the contribution of important socio-economic components on pancreatic cancer rates using a decomposition approach. STUDY
DESIGN: Global ecological study.
METHODS: Incidence and mortality rates of pancreatic cancer were obtained for 172 countries from GLOBOCAN and the United Nations Development Program. The World Bank database was also used to obtain the HDI and its gradient for 169 countries. Inequality in pancreatic cancer age-specific incidence and mortality rates was calculated according to the HDI using the concentration index (CI). We decomposed the CI to determine main contributors of the inequality.
RESULTS: The CI for incidence and mortality of pancreatic cancer in both genders according to the HDI was 0.26 (95% confidence interval: 0.21-0.30) and 0.25 (95% confidence interval: 0.21-0.30), respectively, which indicated more concentrated inequality in advantaged countries. About 80% of the inequality sources were predicted by socio-economic component in both rates of pancreatic cancer. The main contributors to inequality were the mean years of schooling, life expectancy at birth, expected years of schooling, and urbanization.
CONCLUSION: Global inequalities exist in pancreatic cancer incidence and mortality rates according to the HDI; in addition, inequality was more concentrated in countries with higher score of HDI.
Copyright © 2017 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Decomposition; Human Development Index; Incidence; Mortality; Pancreatic cancer

Mesh:

Year:  2018        PMID: 29408193     DOI: 10.1016/j.puhe.2017.12.015

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  6 in total

1.  Role of 3D Volumetric and Perfusion Imaging for Detecting Early Changes in Pancreatic Adenocarcinoma.

Authors:  Syed Rahmanuddin; Ronald Korn; Derek Cridebring; Erkut Borazanci; Jordyn Brase; William Boswell; Asma Jamil; Wenli Cai; Aqsa Sabir; Pejman Motarjem; Eugene Koay; Anirban Mitra; Ajay Goel; Joyce Ho; Vincent Chung; Daniel D Von Hoff
Journal:  Front Oncol       Date:  2021-09-08       Impact factor: 5.738

2.  Dauricine suppresses the growth of pancreatic cancer in vivo by modulating the Hedgehog signaling pathway.

Authors:  Ying-Bo Zhang; Hong-Xin Fei; Jia Guo; Xiao-Jie Zhang; Shu-Liang Wu; Li-Li Zhong
Journal:  Oncol Lett       Date:  2019-09-03       Impact factor: 2.967

3.  Spatiotemporal Trends in the Incidence of Gastrointestinal Neoplasms in Wuwei City of Northwestern China From 1995 to 2016: A Hospital-Based Retrospective Observational Study.

Authors:  Kun Liu; Shuxuan Song; Ting Fu; Yiwen Liu; Hui Zhang; Min Yan; Zhen He; Weilu Zhang; Haixia Su; Zhao Li; Zhaohua Ji; Zhongjun Shao
Journal:  Front Oncol       Date:  2021-09-03       Impact factor: 6.244

4.  Global Burden of cardiomyopathy and myocarditis in the older adults from 1990 to 2019.

Authors:  Kexin Zhang; Xuebing Cheng; Na Qu; Hongwei Song; Youhong Luo; Tongtong Ye; Qian Xu; Hongzhan Tian; Chengxia Kan; Ningning Hou
Journal:  Front Public Health       Date:  2022-09-23

5.  Ubiquitin-specific protease 14 (USP14) promotes proliferation and metastasis in pancreatic ductal adenocarcinoma.

Authors:  Cheng Hang; Chen Gong; Yanfei Fang; Long Chen; Jianxin Zhu
Journal:  J Mol Histol       Date:  2021-01-04       Impact factor: 2.611

Review 6.  Non-Melanoma Skin Cancers: Biological and Clinical Features.

Authors:  Mauro Cives; Francesco Mannavola; Lucia Lospalluti; Maria Chiara Sergi; Gerardo Cazzato; Elisabetta Filoni; Federica Cavallo; Giuseppe Giudice; Luigia Stefania Stucci; Camillo Porta; Marco Tucci
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.